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INTRODUCTION AND OBJECTIVES
CONTROVERSY AND LEGISLATION
The initial application of the genetically modified animals was to contribute in the basic
research with the aim to study the function mechanisms of the organism and to achieve a
better understanding of genes function.
A transgenic animal is one that has been genetically modified either through the insertion
of exogenous genes, or from the elimination or modification of their own genes. The goal is
to modify existing features or to add new ones.
The target of this review is to show the main applications of genetically modified animals. 
On the other hand, a second aim is to show the controversy generated by the use of these 
animals as well as the legislation that is responsible for its regulation.
GENETICALLY ENGINEERED LIVESTOCK: APPLICATIONS IN FOOD PRODUCTION AND 
MEDICINE
Originally, transgenic mammals were created through a technique called pronuclear
microinjection.
The lack of efficiency of this technique has given place to research of new methods to
obtain transgenic animals such as retroviral vectors or somatic cell nuclear transfer (SCNT).
Recent advances in genome editing have allowed the creation of designer engineered
nucleases like ZFN, TALEN and CRISPR/Cas9. These nucleases allow a precise genome
editing in livestock. Its mechanism of action is based on the creation of a double-stranded
break in the DNA with the aim to stimulate the DNA repair pathway.
Figure 1. Structure of ZFN, TALEN and CRISPR/Cas9.        From: Garcia i Pujol (2015)
Models of disease
Disease resistance
Environment
Growth and yield
Livestock have been proposed to overcome the limitations of mice as models of disease
because they share anatomical and physiological characteristics with humans. However,
they have some limitations, such as production cost or time to be invested to develop
similar diseases to those of humans.
• Sheep as models of diseases
of the respiratory system
(ex: asthma, cystic fibrosis)
• Pigs as models of cardiovascular
diseases (ex. Atherosclerosis)
Pigs as models of neurodegenerative
diseases (ex. Alzheimer)
• Goats have been
used in research
on cystic fibrosis
 To solve a 
problem of 
animal welfare
 To prevent the 
spread of 
zoonotic diseases
 To reduce 
the use of 
antibiotics
Why?
Studies: Calves more resistant to mastitis
Liu et al. (2013) Liu et al. (2014)
Worked with lisostafina 
(enzyme with antibacterial 
activity)
Worked with human lysozyme 
(antimicrobial protein)
Integration through ZFNickases Integration through ZFN 
Target gene: β-casein locus Target gene: β-casein locus 
Figure 4. Transgenic 
lamb with muscular 
hypertrophy.              
From: Proudfoot et al. 
(2015)
Figure 3. Calves with MSTN biallelic mutations displayed the 
doubled-muscled phenotype.              From: Luo et al. (2014)
Figure 5. Note that MSTN−/− 
pigs show wider back, fuller 
rump and thicker limbs.     
From: Qian et al. (2015)
Figure 6. Differences in growth between 
AquAdvantage Salmon and conventional during 
the first three years of life.  
From: AquaBounty Technologies
In order to increase production many studies have been
conducted to achieve an increase in muscle mass. Some
studies have been working with the gene MSTN, which
encodes for the miostatina, a protein that plays an
important inhibitory role during muscle development.
Studies Species Technique
Luo et al (2014) Cattle ZFN
Zhao et al. 
(2016)
Sheep TALEN
Proudfoot et al. 
(2015)
Sheep and 
cattle TALEN
Qian et al. 
(2015) Pig ZFN 
Moreover, AquaBounty Technologies created
a transgenic salmon that grows twice as big
and at a greater speed than conventional
ones.
MSTN -/-
MSTN -/-
CONCLUSIONS
Controversy
APPLICATIONS OF GENETICALLY ENGINEERED LIVESTOCK
Pros Cons 
Improve animal health Public resistance to GE 
technology
Reduce the use of antibiotics Perceived lack of safety in
food from GE animals 
Decreased environmental 
impact of farming
Threat to the environment 
(introduction of modified 
genes into wild populations)
Legislation
The EU has established a legal framework to ensure the protection of
human and animal health as well as the environment.
Regulation of evaluation and authorization of genetically modified food
is determined by:
- Directive 2001/18 / EC
- Regulation (EC) Nº 1829/2003
- Regulation 503/2013
 The techniques to obtain genetically modified animals have advanced greatly in recent years.
 Thanks to the development of nucleases design, we can today mimic natural mutations by placing specific
modifications in the genome.
 Many studies aim to produce transgenic animals for human consumption. However, most of these animals are
only under investigation at present.
 Only AquAdvantage salmon has currently been approved for human consumption.
 Despite the advantages that genetically modified animals could pose, these studies can not come to everyday
use until public opinion is not favourable.
METHODS OF MAKING TRANSGENIC ANIMALS
Global animal phosphorus pollution is a
serious and growing problem.
Monogastric animals can not digest
phytate plant, so they required dietary
supplementation with mineral phosphate.
Study
Golovan et al. (2001) have developed the
phytase transgenic pig. The saliva of these
pigs contains phytase, which allows a
complete digestion of dietary phytate.
Figure 2. Phytase transgenic pig.                               
From: http://www.uoguelph.ca/enviropig/
